WMT
120.8
+1.54%↑
COST
966.71
-0.51%↓
PG
144.02
-0.41%↓
KO
75.18
+0.55%↑
PM
163.47
+0.29%↑
WMT
120.8
+1.54%↑
COST
966.71
-0.51%↓
PG
144.02
-0.41%↓
KO
75.18
+0.55%↑
PM
163.47
+0.29%↑
WMT
120.8
+1.54%↑
COST
966.71
-0.51%↓
PG
144.02
-0.41%↓
KO
75.18
+0.55%↑
PM
163.47
+0.29%↑
WMT
120.8
+1.54%↑
COST
966.71
-0.51%↓
PG
144.02
-0.41%↓
KO
75.18
+0.55%↑
PM
163.47
+0.29%↑
WMT
120.8
+1.54%↑
COST
966.71
-0.51%↓
PG
144.02
-0.41%↓
KO
75.18
+0.55%↑
PM
163.47
+0.29%↑
24h
Curent
Minim
14.6
Maxim
15.17
Venit | 42M 85M |
|---|---|
Vânzări | 9.3M 1.3B |
P/E Medie Sector | 7.014 28.772 |
Marjă de profit | 6.633 |
Angajați | 8,500 |
EBITDA | -53M 106M |
Recomandări | Neutru |
|---|---|
Prognoză pe 12 luni | +15.57% upside |
Următoarele câștiguri | 29 apr. 2026 |
|---|
Capitalizare de piață | -62M 1.6B |
|---|---|
Deschiderea anterioară | 14.39 |
Închiderea anterioară | 14.73 |
By Trading Central
Încredere
Weak Bullish Evidence
6.9183 / 7.2 Suport & Rezistență
Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.
23 mar. 2026, 23:47 UTC
Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update
DJ
Citește
23 mar. 2026, 22:55 UTC
Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion
DJ
Citește
23 mar. 2026, 21:51 UTC
Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update
DJ
Citește
23 mar. 2026, 23:59 UTC
Global Equities Roundup: Market Talk
DJ
Citește
23 mar. 2026, 23:59 UTC
Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk
DJ
Citește
23 mar. 2026, 23:50 UTC
Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk
DJ
Citește
23 mar. 2026, 23:37 UTC
Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk
DJ
Citește
23 mar. 2026, 22:42 UTC
Global Equities Roundup: Market Talk
DJ
Citește
23 mar. 2026, 22:42 UTC
Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk
DJ
Citește
23 mar. 2026, 22:40 UTC
Gilead Sciences to Buy Ouro Medicines for Up to $2.18B
DJ
Citește
23 mar. 2026, 22:23 UTC
Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk
DJ
Citește
23 mar. 2026, 22:22 UTC
Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease
DJ
Citește
23 mar. 2026, 22:21 UTC
Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales
DJ
Citește
23 mar. 2026, 22:21 UTC
Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China
DJ
Citește
23 mar. 2026, 22:20 UTC
Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD
DJ
Citește
23 mar. 2026, 22:20 UTC
Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD
DJ
Citește
23 mar. 2026, 22:19 UTC
Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders
DJ
Citește
23 mar. 2026, 22:19 UTC
Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets
DJ
Citește
23 mar. 2026, 22:18 UTC
Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD
DJ
Citește
23 mar. 2026, 22:15 UTC
Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD
DJ
Citește
23 mar. 2026, 22:08 UTC
Ebos Needs to Reset Its Gearing Targets -- Market Talk
DJ
Citește
23 mar. 2026, 21:42 UTC
Global Forex and Fixed Income Roundup: Market Talk
DJ
Citește
23 mar. 2026, 21:42 UTC
RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk
DJ
Citește
23 mar. 2026, 21:32 UTC
WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK
DJ
Citește
23 mar. 2026, 21:32 UTC
WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK
DJ
Citește
23 mar. 2026, 21:32 UTC
WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK
DJ
Citește
23 mar. 2026, 21:10 UTC
Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com
DJ
Citește
23 mar. 2026, 20:50 UTC
Tech, Media & Telecom Roundup: Market Talk
DJ
Citește
23 mar. 2026, 20:50 UTC
Health Care Roundup: Market Talk
DJ
Citește
23 mar. 2026, 20:50 UTC
Basic Materials Roundup: Market Talk
DJ
Citește
Modificare preț
By TipRanks
Prognoză pe 12 luni
Medie 17 USD 15.57%
Maxim 25 USD
Minim 9 USD
În baza a 4 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruHerbalife Ltd - Dist în ultimele 3 luni.
By TipRanks
Neutru
4 ratings
2
Cumpărare
1
Păstrare
1
Vânzare
Ținând cont de 4 analiști care au acordat evaluări ale acțiunilor Herbalife Ltd - Dist în ultimele 3 luni.
By Trading Central
Termen scurt
Weak Bullish Evidence
Recent bullish events outweigh bearish events.
Termen mediu
Neutral Evidence
The bullish and bearish events are balanced.
Termen lung
Bearish Evidence
All events are bearish.
Cheltuieli de vânzare și administrare
Cheltuieli de exploatare
Profit pre-impozitare
Vânzări
Costul vânzărilor
Profit brut din vânzări
Cheltuieli cu dobânzile pe datorie
EBITDA
Profit operațional
$